HADD Science Presents a Best Practice at the AI-based Biomaterial Convergence Program Performance-Sharing Session

On November 12, 2026, CEO Chaejung Heo presented "Tailored Biomaterials through AI-based Medical Information Analysis" as a best practice among participating companies at the final evaluation committee and performance-sharing session of the 2026 AI-based Biomaterial Convergence Product Support Program, held at Courtyard by Marriott Seoul Myeongdong.

AI-Prescribed Biomaterials, a Best Practice. Discover haddscience. @haddscience
chapter 01. Presenting a Best Practice 🎤. On November 12, at Courtyard by Marriott Seoul Myeongdong, HADD Science presented a participant best practice at the final evaluation committee and performance-sharing session of the 2026 AI-based Biomaterial Convergence Product Support Program.
chapter 02. Tailored Biomaterials. In a 10-minute talk, CEO Chaejung Heo presented "Tailored Biomaterials through AI-based Medical Information Analysis." The program is run by the Korea Total Healthcare Ecosystem Association, and HADD Science was selected as a best practice among participating companies.
chapter 03. Four Months, Four Partners 🤝. SSL Co., Ltd.. AI prescription platform. Korea Brain Research Institute. Advice on in vivo similarity validation. DADA Science. Materials for pre-tests and prototypes. K-Biolabs. Materials for productization
chapter 04. AI Prescribes the ECM 💻. 6 public DBs & literature sources. 42 data groups across 12 organs. 76 components per prescription. With SSL's AI prescription platform, we derived ECM compositions and secured mass-based formulations for normal skin, normal scar and normal brain.
chapter 05. From Prototype to Burn Model 🧫. Prototype from the AI formulation. A tailored ECM prototype made with the ADDGEL process. 8 advisory sessions with KBRI. From burn-model design to the final results. Mouse burn model. Recovery progress observed over 16 days of 8 applications
chapter 06. Supported Product: vivoframe. ECM prescribed for each tissue, with compositions formulated by organ and disease, in vial, syringe and freeze-dried forms.
HADD SCIENCE. vivoframe: ECM Prescribed for Each Tissue. From data to prescription, formulation, prototype and biological validation, the full process we planned was carried out in this program. We also filed one patent and two vivoframe trademarks.